Navigation Links
BHR Pharma Announces Phase 3 SyNAPSe Study of Progesterone as a Neuroprotective Agent for Traumatic Brain Injury
Date:9/8/2009

HERNDON, Va., Sept. 8 /PRNewswire/ -- BHR Pharma, LLC (BHR) announced today that it will initiate a global, Phase 3, multi-center pivotal trial (www.synapse-trial.com) to evaluate the effectiveness of its proprietary BHR-100 intravenous progesterone infusion product as a neuroprotective agent for treating severe traumatic brain injury (TBI) patients in early 2010.

BHR will enroll approximately 1,200 patients with severe (Glasgow Coma Scale scores of 4-8), closed-head trauma TBI at 100-120 medical centers in the United States, Europe, Israel and additional countries.

Randomized patients will receive a five-day (120-hour) intravenous infusion of progesterone or placebo. Unlike intravenous progesterone infusions described in the medical literature, BHR-100 is a ready-to-use infusion designed to meet all U.S. Food and Drug Administration approval requirements.

BHR is collaborating with the American Brain Injury Consortium (ABIC) and the European Brain Injury Consortium (EBIC) to identify the trial sites and help design the clinical study. PRA International is the Contract Research Organization for the trial.

TBI is a non-degenerative, non-congenital insult to the brain from an external mechanical force, possibly leading to permanent or temporary impairments of cognitive, physical and psychosocial functions with an associated diminished or altered state of consciousness.

Approximately 1.5 million Americans per year suffer a traumatic brain injury, resulting in 50,000 deaths, 235,000 hospitalizations and 80,000 cases of long-term disability. Incidence of TBI in all industrialized countries is comparable to that in the U.S., with estimates ranging from 150 to more th
'/>"/>

SOURCE BHR Pharma, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. DOR BioPharma Announces NIH Grant Award to Support Phase 1/2 Clinical Trial of DOR201 in Radiation Enteritis
2. LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge
3. Vion Pharmaceuticals Announces Results of the Oncologic Drugs Advisory Committee Meeting for Onrigin(TM)
4. Nitec Pharma Reports Positive and Highly Significant Phase III Results From Capra-2 Study of Lodotra(TM) in RA
5. Sagent Pharmaceuticals Announces Launch of Adenosine Injection, USP, in 6 mg per 2 mL Single-Dose Vials
6. Head of Process Sciences at aTyr Pharma to Speak at Bio Korea 2009
7. Octapharma Targeting the Major Risk of Hemophilia Treatment - FVIII Antibodies
8. ISTA Pharmaceuticals Announces Positive Preliminary Phase 3 Clinical Results to Support sNDA Filing for Once-Daily Xibrom(TM) 0.09%
9. Research-Based Biopharmaceutical Company Awards Trials to DATATRAK
10. NovaBay Pharmaceuticals to Present New Data on Lead Anti-Infective Compound at the 2009 ICAAC Annual Meeting
11. Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... SALT LAKE CITY , July 29, 2014 /PRNewswire/ ... at The Grand American Hotel in Salt ... keynote speakers representing some of most respected healthcare organizations ... Health Catalyst , is an industry conference devoted ... of healthcare analytics,  an essential element of both accountable ...
(Date:7/29/2014)...  Novation, a VHA and UHC company, today ... features that automate key health care supply chain ... Association.  The new and enhanced ... Value Analysis, Item Master and Formulary – are ... most critical challenges brought on by health care ...
(Date:7/29/2014)...   Abide Therapeutics announced today the ... board of directors. Thornberry was previously senior vice ... Merck & Co. Inc., where she led discovery, ... diabetes, osteoporosis, fertility and contraception. Thornberry, a distinguished ... resulted in the discovery of Januvia TM , ...
Breaking Medicine Technology:Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 2Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 3Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 4Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 5Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 2Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 3Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 4Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 5Abide Therapeutics Appoints Nancy Thornberry to Board of Directors 2Abide Therapeutics Appoints Nancy Thornberry to Board of Directors 3
... is accepting applications for the ... or pre-clinical research focused on human protein therapies in ... The application deadline is April 1, 2011. ... protein products manufacturers in the world, launched the Octapharma ...
... 14 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: ... an emerging leader in the development, assembly, marketing ... products in China, today announced that on October ... at the China International Medical Equipment Fair ("CMEF") ...
Cached Medicine Technology:Octapharma Accepting Applications for Research Grants Focused on Human Protein Therapies 2Dehaier Medical Shows New Products at 2010 China International Medical Equipment Fair 2Dehaier Medical Shows New Products at 2010 China International Medical Equipment Fair 3
(Date:7/29/2014)... 30, 2014 VogueQueen.com, a well-known online ... the newest trends in garment fashion by providing graceful ... is selling an all-inclusive array of sexy dresses ... online, a lot of customers take price into consideration. ... That makes the purchase more affordable for all clients. ...
(Date:7/29/2014)... diet rich in soy may help feminine hearts, but ... in Menopause , the journal of The North ... the diet of women in Asia, produces the least ... to Asian migrants to North America, leads to just ... switching to soy from a Western diet after menopause ...
(Date:7/29/2014)... 29, 2014 Daily Gossip indicates in its ... was created for any sufferer who is looking for an ... author of the new program, Sarah Summer, says that her ... from yeast infection, too. Actually, this is the reason why ... problem. , The Natural Cure for Yeast Infection ...
(Date:7/29/2014)... Washington, New York (PRWEB) July 29, 2014 ... to protecting the rights of victims injured by defective ... lawsuit has been filed by plaintiffs in Canada who ... risk of cardiovascular events with the low testosterone ... filed on July 22, 2014 in the Ontario Superior ...
(Date:7/29/2014)... 29, 2014 Regardless of the good ... special someone to share those with. Love is about ... , Love is also about overcoming all the ... have that perfect relationship, women need to know how ... the Enchant Him program, please visit the official website ...
Breaking Medicine News(10 mins):Health News:VogueQueen.com Now Provides Graceful And Sexy Lingerie Collection For August 2Health News:Soy may help women's hearts if they start early 2Health News:Natural Cure for Yeast Infection Review Reveals Sarah Summer’s Healing Method 2Health News:Class Action Lawsuit in Canada Alleges Manufacturer of Delatestryl Testosterone Injection Failed to Warn of Cardiovascular Risks, Parker Waichman LLP Reports 2Health News:Class Action Lawsuit in Canada Alleges Manufacturer of Delatestryl Testosterone Injection Failed to Warn of Cardiovascular Risks, Parker Waichman LLP Reports 3Health News:How to Reach the Heart of the Perfect Guy with "Enchant Him Program" - a Report by Daily Gossip Magazine 2
... It,s Our Money and Our Lives-Time to Take Control of Our Health Care , ... , , ... ... CHICAGO , March 11 Patient care ...
... , March 11 As reported in today,s ... Americans with atrial fibrillation are now on notice that the over-zealous ... are not approved by the U.S. Food and Drug Administration (FDA) ... doctors, and hospitals, decisions about treatment for their patients, heart conditions. ...
... scientists at the University of Leicester have made a new ... cancer and other disease such as Lupus and rheumatoid arthritis. ... Nature Immunology . http://www.nature.com/ni/index.html The work has ... Unit at the University of Leicester. Dr Melania Capasso, ...
... While there are many benefits of losing weight, weight ... weight loss, bones are being remodeled - breaking down old ... As a result, bone density is reduced, causing increased fragility. ... weight-bearing exercise, in this case, fast walking or jogging, did ...
... ... giving relief to contractors and property owners under the new rules. The effectiveness ... costs in the highly competitive business of renovations and repair. , ... Denver, CO (PRWEB) March 11, 2010 ...
... ... that help consumers find low-cost prescription alternatives, has launched its new web site complete ... a clear roadmap to follow in working with their doctor to choose lower priced ... ...
Cached Medicine News:Health News:Patient Safety Week - March 7-12, 2010 2Health News:Patient Safety Week - March 7-12, 2010 3Health News:Whistleblower Alerts Americans to Dangers of Risky Unapproved Treatment for Atrial Fibrillation 2Health News:Whistleblower Alerts Americans to Dangers of Risky Unapproved Treatment for Atrial Fibrillation 3Health News:Whistleblower Alerts Americans to Dangers of Risky Unapproved Treatment for Atrial Fibrillation 4Health News:Whistleblower Alerts Americans to Dangers of Risky Unapproved Treatment for Atrial Fibrillation 5Health News:Whistleblower Alerts Americans to Dangers of Risky Unapproved Treatment for Atrial Fibrillation 6Health News:Weight-bearing exercise does not prevent increased bone turnover during weight loss 2Health News:EPA's New Lead-Based Paint (LBP) Renovation, Repair and Painting Rule (RRP) Causes Headaches for Contractors and Property Owners Alike 2Health News:EPA's New Lead-Based Paint (LBP) Renovation, Repair and Painting Rule (RRP) Causes Headaches for Contractors and Property Owners Alike 3Health News:Find Safe, Affordable Prescription Alternatives at SplitMed.com - New Site for Discount Prescription Drugs 2
For the qualitative detection of human Chorionic Gonadotrophin (hCG) in urine or serum specimens...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Medicine Products: